The effect of bergamot on dyslipidemia
The effect of bergamot on dyslipidemia
复制标题
DOI：
10.1016/j.phymed.2015.12.005
复制
发表时间：
2016-10-15
期刊：
影响因子：
7.9
通讯作者：
Rizzo, Manfredi
中科院分区：
文献类型：
--
作者：
Giglio, Rosaria Vincenza;Patti, Angelo Maria;Rizzo, Manfredi
Background: Statins are the most common used lipid lowering drugs but they may cause adverse effects and despite their well-established therapeutic benefits residual cardiovascular (CV) risk remains. The use of other lipid lowering drugs and nutraceuticals alone or as add-on lipid-modifying therapy can be an option in such cases. Several studies have reported health-related properties of the Citrus fruits, among which bergamot (Citrus bergamia Risso) differs from others by particularly high content of certain compounds.Purpose: This narrative review summarizes the current evidence on the effects of bergamot on lipid parameters based on studies involving animals and humans.Main evidence: This natural supplement may lead to effective lipid-lowering treatment. Its lipid-lowering activity is attributed to different flavonoids. However, the exact mechanisms involved remain unclear.Conclusion: It is expected that ongoing and future studies will confirm the benefit of bergamot in dyslipidemic and other cardiometabolic disorders, potentially leading to reduced overall CV risk. (C) 2016 Published by Elsevier GmbH.
